Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients

W. Bosch, M. G. Heckman, N. N. Diehl, J. A. Shalev, Surakit Pungpapong, W. C. Hellinger

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been inconsistently associated with increased mortality in liver transplant (LT) recipients. A retrospective study evaluating the association of CMV infection and disease occurring within 1 year of transplant with the endpoints of death or the combined endpoint of graft loss or death was undertaken in a cohort of 227 CMV donor seropositive, recipient seronegative first LT recipients. Associations were evaluated using Cox proportional hazards regression models. CMV infection and disease occurred in 91 (40%) and 43 (19%) patients, respectively. Forty-eight (21%) died while 58 (26%) sustained graft loss or death. In multivariable analysis, CMV infection was associated with an increased risk of death (RR: 2.24, p = 0.008) and graft loss or death (RR: 2.85, p < 0.001). CMV disease was also associated with an increased risk of death (RR: 2.73, p = 0.003) and graft loss or death (RR: 3.04, p = 0.001). CMV infection and disease occurring within the first year after LT in high-risk recipients is associated with increased risk of death and of graft loss or death. Investigation of strategies to further reduce the risk of CMV infection and disease in high-risk LT recipients is warranted.

Original languageEnglish (US)
Pages (from-to)2181-2189
Number of pages9
JournalAmerican Journal of Transplantation
Volume11
Issue number10
DOIs
StatePublished - Oct 1 2011

Fingerprint

Cytomegalovirus Infections
Transplants
Liver
Cytomegalovirus
Chemoprevention
Proportional Hazards Models
Antiviral Agents
Retrospective Studies
Tissue Donors
Mortality

Keywords

  • Cytomegalovirus (CMV)
  • death
  • graft failure
  • graft loss
  • liver transplantation
  • mortality

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients. / Bosch, W.; Heckman, M. G.; Diehl, N. N.; Shalev, J. A.; Pungpapong, Surakit; Hellinger, W. C.

In: American Journal of Transplantation, Vol. 11, No. 10, 01.10.2011, p. 2181-2189.

Research output: Contribution to journalArticle

Bosch, W. ; Heckman, M. G. ; Diehl, N. N. ; Shalev, J. A. ; Pungpapong, Surakit ; Hellinger, W. C. / Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients. In: American Journal of Transplantation. 2011 ; Vol. 11, No. 10. pp. 2181-2189.
@article{e3080caf240e47ba9cae6beca0bb1dd2,
title = "Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients",
abstract = "In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been inconsistently associated with increased mortality in liver transplant (LT) recipients. A retrospective study evaluating the association of CMV infection and disease occurring within 1 year of transplant with the endpoints of death or the combined endpoint of graft loss or death was undertaken in a cohort of 227 CMV donor seropositive, recipient seronegative first LT recipients. Associations were evaluated using Cox proportional hazards regression models. CMV infection and disease occurred in 91 (40{\%}) and 43 (19{\%}) patients, respectively. Forty-eight (21{\%}) died while 58 (26{\%}) sustained graft loss or death. In multivariable analysis, CMV infection was associated with an increased risk of death (RR: 2.24, p = 0.008) and graft loss or death (RR: 2.85, p < 0.001). CMV disease was also associated with an increased risk of death (RR: 2.73, p = 0.003) and graft loss or death (RR: 3.04, p = 0.001). CMV infection and disease occurring within the first year after LT in high-risk recipients is associated with increased risk of death and of graft loss or death. Investigation of strategies to further reduce the risk of CMV infection and disease in high-risk LT recipients is warranted.",
keywords = "Cytomegalovirus (CMV), death, graft failure, graft loss, liver transplantation, mortality",
author = "W. Bosch and Heckman, {M. G.} and Diehl, {N. N.} and Shalev, {J. A.} and Surakit Pungpapong and Hellinger, {W. C.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1111/j.1600-6143.2011.03618.x",
language = "English (US)",
volume = "11",
pages = "2181--2189",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients

AU - Bosch, W.

AU - Heckman, M. G.

AU - Diehl, N. N.

AU - Shalev, J. A.

AU - Pungpapong, Surakit

AU - Hellinger, W. C.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been inconsistently associated with increased mortality in liver transplant (LT) recipients. A retrospective study evaluating the association of CMV infection and disease occurring within 1 year of transplant with the endpoints of death or the combined endpoint of graft loss or death was undertaken in a cohort of 227 CMV donor seropositive, recipient seronegative first LT recipients. Associations were evaluated using Cox proportional hazards regression models. CMV infection and disease occurred in 91 (40%) and 43 (19%) patients, respectively. Forty-eight (21%) died while 58 (26%) sustained graft loss or death. In multivariable analysis, CMV infection was associated with an increased risk of death (RR: 2.24, p = 0.008) and graft loss or death (RR: 2.85, p < 0.001). CMV disease was also associated with an increased risk of death (RR: 2.73, p = 0.003) and graft loss or death (RR: 3.04, p = 0.001). CMV infection and disease occurring within the first year after LT in high-risk recipients is associated with increased risk of death and of graft loss or death. Investigation of strategies to further reduce the risk of CMV infection and disease in high-risk LT recipients is warranted.

AB - In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been inconsistently associated with increased mortality in liver transplant (LT) recipients. A retrospective study evaluating the association of CMV infection and disease occurring within 1 year of transplant with the endpoints of death or the combined endpoint of graft loss or death was undertaken in a cohort of 227 CMV donor seropositive, recipient seronegative first LT recipients. Associations were evaluated using Cox proportional hazards regression models. CMV infection and disease occurred in 91 (40%) and 43 (19%) patients, respectively. Forty-eight (21%) died while 58 (26%) sustained graft loss or death. In multivariable analysis, CMV infection was associated with an increased risk of death (RR: 2.24, p = 0.008) and graft loss or death (RR: 2.85, p < 0.001). CMV disease was also associated with an increased risk of death (RR: 2.73, p = 0.003) and graft loss or death (RR: 3.04, p = 0.001). CMV infection and disease occurring within the first year after LT in high-risk recipients is associated with increased risk of death and of graft loss or death. Investigation of strategies to further reduce the risk of CMV infection and disease in high-risk LT recipients is warranted.

KW - Cytomegalovirus (CMV)

KW - death

KW - graft failure

KW - graft loss

KW - liver transplantation

KW - mortality

UR - http://www.scopus.com/inward/record.url?scp=80053319207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053319207&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2011.03618.x

DO - 10.1111/j.1600-6143.2011.03618.x

M3 - Article

VL - 11

SP - 2181

EP - 2189

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 10

ER -